Polypeptide medicine and polypeptide ablation technology

Abstract

The invention discloses polypeptide medicine and a polypeptide ablation technology. The polypeptide medicine and the polypeptide ablation technology are applied to treating gout. Polypeptides comprise antibacterial active peptides, small cytokine peptides, immune active peptides and neural active peptides. The polypeptide ablation technology is applied to removing inflammatory substances in joint cavities, softening and ablating gout crystals, purifying blood and recovering body immune and metabolism functions. The polypeptide medicine and the polypeptide ablation technology have the advantages that the inflammatory substances in the joint cavities can be removed, the gout crystals can be softened and ablated, and accordingly symptoms such as pain, redness and swelling, joint deformity and activity limitation can disappear; the blood can be purified, so that the normal body immune and metabolism functions can be compelled from blood sources, and recurrent pathogenic conditions can be prevented; in-vivo old cells can be regulated at one step, so that hyperuricemia can be thoroughly treated; tophus can be eliminated, and lesion joints can be repaired; purine nucleotide can be decomposed, and complications can be prevented; joint tissue metabolism can be improved, and recurrence can be completely eradicated.

Description

technical field [0001] The invention relates to the fields of medicine and medicine, in particular to a polypeptide drug and a polypeptide ablation technology, which are applied to the treatment of diseases such as gout. Background technique [0002] Gout is more common in middle-aged men, and women are mainly postmenopausal women, and the incidence of gout tends to be younger. The natural history of gout can be divided into four stages, namely asymptomatic hyperuricemia stage, acute stage, intermittent stage, and chronic stage. The etiology of gout is clear, but in the early stage, many people often neglected the treatment of the pathogenic source, which led to the more and more serious disease, resulting in tophi and systemic complications of the viscera. Therefore, the treatment of the cause of gout cannot be ignored. However, conventional drug therapy is currently used for the treatment of gout. Anti-inflammatory analgesia in the acute phase and uric acid-lowering thera...

AI Technical Summary

Problems solved by technology

Therefore, the treatment of the etiology of gout should not be ignored, but at present, conventional drug therapy is mostly used in the treatment of gout. Anti-inflammatory pain relief in the acute stage and uric acid-lowering therapy in the remission stage are selected, but the therapeutic effect is not ideal